Philippa Gardner has over 15 years of experience as a healthcare sell side analyst, including at Lehman Brothers and Jefferies. During her time she mostly covered European drug development companies, from biotech through to large cap pharma, and has worked on a number of IPOs and secondary financings. She also spent a year working in healthcare strategic communications advisory.

She holds a Doctorate in Biochemical Engineering (EngD) and an MEng in Chemical with Biochemical Engineering, both from University College London.